.Pharmacolibrary.Drugs.S_SensoryOrgans.S01E_AntiglaucomaPreparationsAndMiotics.S01EC05_Methazolamide.Methazolamide .Pharmacolibrary.Drugs.S_SensoryOrgans.S01E_AntiglaucomaPreparationsAndMiotics.S01EC05_Methazolamide.Methazolamide| name: | Methazolamide | |
| ATC code: | S01EC05 | route: | oral |
| compartments: | 1 | |
| dosage: | 50 | mg |
| volume of distribution: | 0.2 | L |
| clearance: | 0.14 | L/h/kg |
| other parameters in model implementation | ||
Methazolamide is a carbonic anhydrase inhibitor used primarily in the treatment of glaucoma to reduce intraocular pressure. It is approved and in clinical use today for the management of ocular hypertension and some forms of epilepsy.
Pharmacokinetic parameters reported for healthy adult volunteers following single oral administration.